GSK plc GSK announced that the FDA expanded Boostrix’s label for immunization during pregnancy to help prevent pertussis (whooping cough) in infants not older than two months. Following the label ...
Boostrix is a brand-name booster vaccine that’s prescribed to help prevent tetanus, diphtheria, and pertussis. The cost of the vaccine with and without insurance can depend on several factors, such as ...
NEW YORK, July 8, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] ...
(RTTNews) - The FDA has approved GSK plc's (GSK) Boostrix vaccine for immunization during the third trimester of pregnancy to prevent pertussis, commonly known as whooping cough, in infants younger ...
NEW YORK, July 8, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] ...
April 20, 2009 — The tetanus toxoid/reduced diphtheria toxoid/acellular pertussis single-dose booster vaccine (Tdap; Boostrix, GlaxoSmithKline Biologicals) was approved for an expanded age indication ...
The U.S. Food and Drug Administration has approved Boostrix for immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age. The Boostrix vaccine ...
Teva, the largest US supplier of Adderall, expects shortages to continue for the next 2-3 months; FDA expands use of Boostrix for immunization during the third trimester of pregnancy to prevent ...
BOOSTRIX (Tetanus and reduced diphtheria toxoid, acellular pertussis vaccine) by GlaxoSmithKline GlaxoSmithKline's combination vaccine Boostrix (tetanus toxoid, reduced diphtheria toxoid, and ...
Portrait of young happy pregnant woman standing by the window Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy ...
PHILADELPHIA, PA--(MARKET WIRE)--Dec 8, 2008 -- GlaxoSmithKline (NYSE:GSK - News) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results